| Product Code: ETC8561173 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, New Zealand saw a steady influx of gram-positive bacterial infection imports, with key exporting countries including Australia, Italy, USA, Metropolitan France, and India. Despite the market being dominated by these top players, the Herfindahl-Hirschman Index (HHI) indicated a low concentration of market share. The compound annual growth rate (CAGR) for the period 2020-2024 was an impressive 24.16%, although there was a slight decline in growth rate from 2023 to 2024 at -3.31%. This data suggests a dynamic market with opportunities for continued expansion and diversification in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Gram-positive Bacterial Infections Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Gram-positive Bacterial Infections Market Revenues & Volume, 2022 & 2032F |
3.3 New Zealand Gram-positive Bacterial Infections Market - Industry Life Cycle |
3.4 New Zealand Gram-positive Bacterial Infections Market - Porter's Five Forces |
3.5 New Zealand Gram-positive Bacterial Infections Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 New Zealand Gram-positive Bacterial Infections Market Revenues & Volume Share, By Disease, 2022 & 2032F |
3.7 New Zealand Gram-positive Bacterial Infections Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.8 New Zealand Gram-positive Bacterial Infections Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 New Zealand Gram-positive Bacterial Infections Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gram-positive bacterial infections in New Zealand |
4.2.2 Rising awareness about the importance of appropriate treatment for bacterial infections |
4.2.3 Technological advancements leading to the development of new and more effective treatment options |
4.3 Market Restraints |
4.3.1 Growing concern and regulations around antibiotic resistance |
4.3.2 High costs associated with the development and manufacturing of new antibiotics |
4.3.3 Limited availability of healthcare resources and infrastructure in certain regions of New Zealand |
5 New Zealand Gram-positive Bacterial Infections Market Trends |
6 New Zealand Gram-positive Bacterial Infections Market, By Types |
6.1 New Zealand Gram-positive Bacterial Infections Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Gram-positive Bacterial Infections Market Revenues & Volume, By Drug Type, 2022 - 2032F |
6.1.3 New Zealand Gram-positive Bacterial Infections Market Revenues & Volume, By Antibiotic, 2022 - 2032F |
6.1.4 New Zealand Gram-positive Bacterial Infections Market Revenues & Volume, By Antifungal, 2022 - 2032F |
6.1.5 New Zealand Gram-positive Bacterial Infections Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 New Zealand Gram-positive Bacterial Infections Market, By Disease |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Gram-positive Bacterial Infections Market Revenues & Volume, By MRSA, 2022 - 2032F |
6.2.3 New Zealand Gram-positive Bacterial Infections Market Revenues & Volume, By Pneumonia, 2022 - 2032F |
6.2.4 New Zealand Gram-positive Bacterial Infections Market Revenues & Volume, By Sepsis, 2022 - 2032F |
6.2.5 New Zealand Gram-positive Bacterial Infections Market Revenues & Volume, By Sinusitis, 2022 - 2032F |
6.2.6 New Zealand Gram-positive Bacterial Infections Market Revenues & Volume, By Cellulitis, 2022 - 2032F |
6.2.7 New Zealand Gram-positive Bacterial Infections Market Revenues & Volume, By Otitis, 2022 - 2032F |
6.3 New Zealand Gram-positive Bacterial Infections Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 New Zealand Gram-positive Bacterial Infections Market Revenues & Volume, By Enteral, 2022 - 2032F |
6.3.3 New Zealand Gram-positive Bacterial Infections Market Revenues & Volume, By Parenteral, 2022 - 2032F |
6.3.4 New Zealand Gram-positive Bacterial Infections Market Revenues & Volume, By Others (Topical, Transdermal), 2022 - 2032F |
6.4 New Zealand Gram-positive Bacterial Infections Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 New Zealand Gram-positive Bacterial Infections Market Revenues & Volume, By Hospitals Pharmacies, 2022 - 2032F |
6.4.3 New Zealand Gram-positive Bacterial Infections Market Revenues & Volume, By Drug Stores and Retail Pharmacies, 2022 - 2032F |
6.4.4 New Zealand Gram-positive Bacterial Infections Market Revenues & Volume, By Others, 2022 - 2032F |
7 New Zealand Gram-positive Bacterial Infections Market Import-Export Trade Statistics |
7.1 New Zealand Gram-positive Bacterial Infections Market Export to Major Countries |
7.2 New Zealand Gram-positive Bacterial Infections Market Imports from Major Countries |
8 New Zealand Gram-positive Bacterial Infections Market Key Performance Indicators |
8.1 Rate of antibiotic resistance in gram-positive bacterial infections |
8.2 Adoption rate of new treatment options in healthcare facilities |
8.3 Percentage of the population receiving appropriate antibiotic therapy for gram-positive bacterial infections |
8.4 Number of research and development initiatives focused on gram-positive bacterial infections |
8.5 Patient outcomes and recovery rates from gram-positive bacterial infections |
9 New Zealand Gram-positive Bacterial Infections Market - Opportunity Assessment |
9.1 New Zealand Gram-positive Bacterial Infections Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 New Zealand Gram-positive Bacterial Infections Market Opportunity Assessment, By Disease, 2022 & 2032F |
9.3 New Zealand Gram-positive Bacterial Infections Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.4 New Zealand Gram-positive Bacterial Infections Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 New Zealand Gram-positive Bacterial Infections Market - Competitive Landscape |
10.1 New Zealand Gram-positive Bacterial Infections Market Revenue Share, By Companies, 2025 |
10.2 New Zealand Gram-positive Bacterial Infections Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here